Understanding Breast Cancer Progression Through DNA Methylation
Author Information
Author(s): Chen Kang Mei, Stephen Josena K., Raju Usha, Worsham Maria J.
Primary Institution: Henry Ford Hospital
Hypothesis
Promoter hypermethylation contributes to the pathogenesis of benign breast lesions along a progression continuum to invasive breast cancer.
Conclusion
Hypermethylation of specific genes is an early event in the progression from benign breast lesions to invasive breast cancer.
Supporting Evidence
- Promoter methylation was detected in 11 out of 22 tumor suppressor genes in 16 out of 17 cases.
- Hypermethylation of RASSF1 was most frequent, present in 14 out of 17 cases.
- Hypermethylation of APC was noted in 12 out of 17 cases.
- Hypermethylation of GSTP1 was observed in 9 out of 17 cases.
Takeaway
This study found that changes in DNA can help us understand how benign breast conditions can turn into cancer.
Methodology
DNA from tumor tissue and various breast lesions was analyzed for promoter methylation status using multiplex ligation-dependent probe amplification and confirmed with methylation-specific PCR.
Limitations
The study was limited to a small cohort of 17 patients and may not be generalizable to all breast cancer cases.
Participant Demographics
The study included 17 breast cancer patients with various benign and in situ lesions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website